Richard J Daly
CIK 1635393 · President and CEO · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.84M
Companies
5
Total Filings
50
Lifetime Open-Market Net
$1.10M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CPRX | President and CEO | 281,843 | $31.36 | $8.84M | $989.8K | 31 | 2026-01-06 |
| OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Director | 0 | $20.65 | $0 | $25.0K | 7 | 2023-03-03 |
| PALISADE BIO, INC. (CUR) Delisted | Chief Executive Officer | 23,312 | — | — | $90.0K | 8 | 2017-11-09 |
| SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Director | — | — | — | $0 | 1 | 2017-06-30 |
| SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | Director | — | — | — | $0 | 3 | 2016-06-29 |
Recent Filings · Page 3 of 5
50 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-14 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
| 2022-02-16 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2022-01-26 | CPRX | Exer (M) | +50,000 | $167.5K | EDGAR |
| 2021-12-30 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2021-12-06 | CPRX | Exer (M) | +1,333 | $0 | EDGAR |
| 2021-06-16 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
| 2021-01-04 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2020-12-28 | CPRX | Exer (M) | +1,333 | $0 | EDGAR |
| 2020-06-15 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
| 2020-03-02 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Buy (P) | +1,800 | $25.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.